Tam Nguyen
About Tam Nguyen
Tam Nguyen is a Senior Associate Scientist in Analytical Development at ElevateBio, where he has worked since 2020. He has a strong background in assay development for lentiviral and adeno-associated virus platforms, with previous experience at Northeastern University and Voyager Therapeutics.
Work at ElevateBio
Tam Nguyen currently serves as a Senior Associate Scientist in Analytical Development at ElevateBio, a role he has held since 2020. In this position, he focuses on developing and pre-qualifying assays for lentiviral vector (LVV) and adeno-associated virus (AAV) platforms. His work includes specific assays such as p24, HEK HCP (ELISA and Automated), residual heparin, osmolality, and single cell VCN. His expertise in these areas contributes to the advancement of gene therapy technologies.
Education and Expertise
Tam Nguyen has a strong educational background in the sciences. He earned an Associate of Science (A.S.) in Biology from Highline College from 2009 to 2011. He then obtained a Bachelor of Science (B.S.) in Biochemistry from Seattle University from 2011 to 2013. Following this, he completed a Master of Science (M.S.) in Medicinal and Pharmaceutical Chemistry at Northeastern University from 2014 to 2016. His academic training has equipped him with expertise in developing assays for LVV and AAV platforms.
Background
Tam Nguyen has a diverse professional background that includes roles in both scientific research and legal assistance. He began his career as a Chemistry tutor at Highline College in 2009. He later worked as a Legal Assistant at Gary Grotz Law Firm, PLLC in 2014. From 2015 to 2016, he served as an In vitro Pharmacology Research Assistant at Northeastern University. He then transitioned to Voyager Therapeutics, Inc., where he worked as a Senior Research Associate and Team Lead from 2016 to 2020.
Achievements
Throughout his career, Tam Nguyen has developed and pre-qualified various assays critical to gene therapy research. His work includes the development of assays for LVV and AAV platforms, showcasing his technical skills in both ELISA and automated assay techniques. His contributions in these areas have supported advancements in the field of analytical development within biotechnology.